Table 5.
Scores of PORPUS-P by age categories and type of therapy to be received (Mean ± SD, Median, 5th and 95th percentiles)
| German reference men [n = 988] | German PC patients with scheduled radiotherapy [n = 121] | German PC patients with scheduled radical prostatectomy [n = 371] | Canadian PC patients with scheduled radiotherapy [n = 66] | Canadian PC patients with scheduled radical prostatectomy [n = 68] | |
|---|---|---|---|---|---|
| Age category [years] | |||||
| 45–49 | n = 253 | n = 13 | n = 1 | n = 1 | |
| 87.0 ± 9.70 | - | 84.8 ± 8.80 | 83.0 | 84.2 | |
| 88.3 (66.8/100) | - | 88.3 (66.8/97.5) | - | - | |
| 50–54 | n = 239 | n = 2 | n = 31 | n = 2 | n = 14 |
| 85.2 ± 11.7 | 77.8 ± 8.61 | 82.3 ± 11.9 | 65.8 ± 13.0 | 92.1 ± 4.4 | |
| 83.3 (61.7/100) | 77.8 (71.7/83.8) | 83.3 (58.2/100) | 65.8 (56.7/75.0) | 91.7 (85.8/100) | |
| 55–59 | n = 162 | n = 10 | n = 57 | n = 4 | n = 18 |
| 83.1 ± 12.0 | 77.1 ± 16.2 | 81.3 ± 12.5 | 84.8 ± 5.1 | 86.5 ± 10.1 | |
| 86.3 (62.2/97.5) | 77.8 (42.7/100) | 84.2 (57.4/95.2) | 82.4 (82.2/92.5) | 87.1 (69.2/100) | |
| 60–64 | n = 166 | n = 26 | n = 117 | n = 9 | n = 17 |
| 80.9 ± 12.1 | 77.6 ± 12.7 | 82.0 ± 11.5 | 80.3 ± 17.4 | 85.5 ± 8.2 | |
| 84.0 (57.2/97.5) | 78.5 (53.9/98.3) | 83.3 (59.2/98.2) | 85.0 (46.3/100) | 86.7 (71.3/97.5) | |
| 65–69 | n = 127 | n = 43 | n = 115 | n = 21 | n = 11 |
| 79.5 ± 13.4 | 76.9 ± 12.5 | 79.8 ± 14.1 | 77.9 ± 10.7 | 78.5 ± 12.5 | |
| 80.8 (57.4/97.5) | 76.7 (52.8/94.8) | 82.7 (52.3/98.0) | 78.8 (65.3/95.0) | 79.2 (55.8/95.0) | |
| 70+ | n = 41 | n = 40 | n = 38 | n = 29 | n = 7 |
| 76.7 ± 15.5 | 77.2 ± 12.4 | 76.8 ± 10.7 | 77.0 ± 10.6 | 78.8 ± 9.1 | |
| 78.8 (49.1/97.5) | 80.4 (52.2/92.5) | 77.8 (56.5/95.0) | 75.0 (62.5/92.5) | 77.5 (67.2/92.5) | |
| Total (Crude values) | 83.5 ± 12.1 | 77.2 ± 12.6 | 80.8 ± 12.4 | 78.0 ± 11.6 | 85.3 ± 9.9 |
| 86.1 (59.8/97.5) | 79.2 (53.5/94.4) | 83.0 (58.0/97.5) | 78.8 (62.5/97.5) | 87.5 (69.2/97.5) | |
| Age-adjusted means (norm: ref. pop.; 50 and older) | 82.3 | 77.4 | 81.3 | 76.0 | 86.3 |